Cite
HARVARD Citation
Schwarzbich, M. et al. (n.d.). Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment. Leukemia & lymphoma. 57 (7), pp. 1723-1726. [Online].